Appel Roni

Avg. Two Year Performance

(74%) Avg. Purchase Return
(32%) Compound
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(8%)22%45%(16%)(74%)
Purchase Success Rate1 of 32 of 32 of 30 of 30 of 3
Average Sale Return(24%)(24%)21%0%0%
Sale Success Rate0 of 10 of 11 of 10 of 10 of 1

Advaxis Inc.

Drugs » Biotechnology

Director:

Holdings: 10.48K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--